Jane Street Group, LLC Cara Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 53,506 shares of CARA stock, worth $279,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,506
Previous 376,502 85.79%
Holding current value
$279,301
Previous $97,000 83.51%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.26 - $0.38 $83,978 - $122,738
-322,996 Reduced 85.79%
53,506 $16,000
Q2 2024

Aug 14, 2024
BUY
$0.24 - $0.92 $90,360 - $346,381
376,502 New
376,502 $97,000
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $56,031 - $154,085
93,385 New
93,385 $69,000
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $470,623 - $821,512
166,298 Added 1220.27%
179,926 $509,000
Q1 2023

May 15, 2023
SELL
$4.89 - $12.27 $226,235 - $567,671
-46,265 Reduced 77.25%
13,628 $66,000
Q4 2022

Feb 14, 2023
BUY
$8.88 - $12.77 $385,907 - $554,958
43,458 Added 264.42%
59,893 $643,000
Q3 2022

Nov 14, 2022
SELL
$8.24 - $12.56 $93,795 - $142,970
-11,383 Reduced 40.92%
16,435 $153,000
Q2 2022

Aug 16, 2022
BUY
$7.45 - $13.84 $77,509 - $143,991
10,404 Added 59.75%
27,818 $254,000
Q1 2022

May 17, 2022
SELL
$9.94 - $12.65 $84,251 - $107,221
-8,476 Reduced 32.74%
17,414 $212,000
Q4 2021

Feb 15, 2022
SELL
$11.99 - $18.14 $2.35 Million - $3.55 Million
-195,590 Reduced 88.31%
25,890 $315,000
Q3 2021

Nov 16, 2021
BUY
$11.55 - $16.06 $2.22 Million - $3.09 Million
192,162 Added 655.44%
221,480 $3.42 Million
Q2 2021

Aug 16, 2021
SELL
$12.38 - $29.19 $186,566 - $439,893
-15,070 Reduced 33.95%
29,318 $418,000
Q1 2021

May 18, 2021
BUY
$15.07 - $21.71 $306,840 - $442,037
20,361 Added 84.74%
44,388 $963,000
Q4 2020

Feb 17, 2021
BUY
$12.72 - $16.16 $39,406 - $50,063
3,098 Added 14.8%
24,027 $364,000
Q3 2020

Nov 17, 2020
BUY
$12.34 - $17.92 $258,263 - $375,047
20,929 New
20,929 $267,000
Q2 2019

Aug 15, 2019
SELL
$17.68 - $21.57 $218,896 - $267,058
-12,381 Closed
0 $0
Q1 2019

May 16, 2019
BUY
$14.41 - $19.64 $178,410 - $243,162
12,381 New
12,381 $243,000
Q4 2018

Feb 15, 2019
SELL
$12.45 - $23.47 $168,149 - $316,985
-13,506 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$17.57 - $23.95 $237,300 - $323,468
13,506 New
13,506 $323,000
Q4 2017

Feb 15, 2018
SELL
$11.86 - $14.08 $152,863 - $181,477
-12,889 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.6 - $16.34 $162,401 - $210,606
12,889
12,889 $176,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $280M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email